banner
MEK inhibitor PD184352 (CI-1040), Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ850

MEK inhibitor PD184352 (CI-1040), Purity ≥98%

Synonym: 212631-79-3; CI-1040; PD184352; PD 184352; PD-184352; 2-(2-Chloro-4-iodophenylamino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide; MEK inhibitor

  • MDL: MFCD02683961
  • CAS Number: 212631-79-3
  • Compound CID: 6918454
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
PD184352 (CI-1040), soluble in DMSO and ethanol and insoluble in water, prevents the phosphorylation and activation of ERK leading to reduced cell proliferation and induced apoptosis in cancerous cells. It targets MEK1 and MEK2.
Molecular Weight
478.7
Molecular Formula
C17H14ClF2IN2O2
Targets
MEK1: 17 nM; MEK2: 17 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 92 mg/mL (192.19 mM); Water: Insoluble; Ethanol: 13 mg/mL (27.15 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
PD184352 (CI-1040) can be used to examine the inhibition of MEK1/2 and its implications in oncogenic signaling pathways.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0